Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer

Sayuri Takahashi, Tomoyuki Watanabe, Maiko Okada, Kazuki Inoue, Takashi Ueda, Ichiro Takada, Tetsuro Watabe, Yoko Yamamoto, Toru Fukuda, Takashi Nakamura, Chihiro Akimoto, Tetsuya Fujimura, Maiko Hoshino, Yuuki Imai, Daniel Metzger, Kohei Miyazono, Yasuhiro Minami, Pierre Chambon, Tadaichi Kitamura, Takahiro Matsumoto & 1 others Shigeaki Kato

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Prostate cancer development is associated with hyperactive androgen signaling. However, the molecular link between androgen receptor (AR) function and humoral factors remains elusive. A prostate cancer mouse model was generated by selectively mutating the AR threonine 877 into alanine in prostatic epithelial cells through Cre-ERT2-mediated targeted somatic mutagenesis. Such AR point mutant mice (ARpe-T877A/Y) developed hypertrophic prostates with responses to both an androgen antagonist and estrogen, although no prostatic tumor was seen. In prostate cancer model transgenic mice, the onset of prostatic tumorigenesis as well as tumor growth was significantly potentiated by introduction of the AR T877A mutation into the prostate. Genetic screening of mice identified Wnt-5a as an activator. Enhanced Wnt-5a expression was detected in the malignant prostate tumors of patients, whereas in benign prostatic hyperplasia such aberrant up-regulation was not obvious. These findings suggest that a noncanonical Wnt signal stimulates development of prostatic tumors with AR hyperfunction.

Original languageEnglish
Pages (from-to)4938-4943
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
Issue number12
DOIs
Publication statusPublished - 2011 Mar 22
Externally publishedYes

Fingerprint

Androgen Receptors
Androgens
Prostatic Neoplasms
Growth
Prostate
Neoplasms
Androgen Antagonists
Prostatic Hyperplasia
Genetic Testing
Threonine
Mutagenesis
Alanine
Transgenic Mice
Estrogens
Carcinogenesis
Up-Regulation
Epithelial Cells
Mutation

Keywords

  • Antiandrogen
  • Hormone-refractory state
  • TRAMP

ASJC Scopus subject areas

  • General

Cite this

Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer. / Takahashi, Sayuri; Watanabe, Tomoyuki; Okada, Maiko; Inoue, Kazuki; Ueda, Takashi; Takada, Ichiro; Watabe, Tetsuro; Yamamoto, Yoko; Fukuda, Toru; Nakamura, Takashi; Akimoto, Chihiro; Fujimura, Tetsuya; Hoshino, Maiko; Imai, Yuuki; Metzger, Daniel; Miyazono, Kohei; Minami, Yasuhiro; Chambon, Pierre; Kitamura, Tadaichi; Matsumoto, Takahiro; Kato, Shigeaki.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, No. 12, 22.03.2011, p. 4938-4943.

Research output: Contribution to journalArticle

Takahashi, S, Watanabe, T, Okada, M, Inoue, K, Ueda, T, Takada, I, Watabe, T, Yamamoto, Y, Fukuda, T, Nakamura, T, Akimoto, C, Fujimura, T, Hoshino, M, Imai, Y, Metzger, D, Miyazono, K, Minami, Y, Chambon, P, Kitamura, T, Matsumoto, T & Kato, S 2011, 'Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer', Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 4938-4943. https://doi.org/10.1073/pnas.1014850108
Takahashi, Sayuri ; Watanabe, Tomoyuki ; Okada, Maiko ; Inoue, Kazuki ; Ueda, Takashi ; Takada, Ichiro ; Watabe, Tetsuro ; Yamamoto, Yoko ; Fukuda, Toru ; Nakamura, Takashi ; Akimoto, Chihiro ; Fujimura, Tetsuya ; Hoshino, Maiko ; Imai, Yuuki ; Metzger, Daniel ; Miyazono, Kohei ; Minami, Yasuhiro ; Chambon, Pierre ; Kitamura, Tadaichi ; Matsumoto, Takahiro ; Kato, Shigeaki. / Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer. In: Proceedings of the National Academy of Sciences of the United States of America. 2011 ; Vol. 108, No. 12. pp. 4938-4943.
@article{3ec1a24b179645c1a26fa6153caec8ac,
title = "Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer",
abstract = "Prostate cancer development is associated with hyperactive androgen signaling. However, the molecular link between androgen receptor (AR) function and humoral factors remains elusive. A prostate cancer mouse model was generated by selectively mutating the AR threonine 877 into alanine in prostatic epithelial cells through Cre-ERT2-mediated targeted somatic mutagenesis. Such AR point mutant mice (ARpe-T877A/Y) developed hypertrophic prostates with responses to both an androgen antagonist and estrogen, although no prostatic tumor was seen. In prostate cancer model transgenic mice, the onset of prostatic tumorigenesis as well as tumor growth was significantly potentiated by introduction of the AR T877A mutation into the prostate. Genetic screening of mice identified Wnt-5a as an activator. Enhanced Wnt-5a expression was detected in the malignant prostate tumors of patients, whereas in benign prostatic hyperplasia such aberrant up-regulation was not obvious. These findings suggest that a noncanonical Wnt signal stimulates development of prostatic tumors with AR hyperfunction.",
keywords = "Antiandrogen, Hormone-refractory state, TRAMP",
author = "Sayuri Takahashi and Tomoyuki Watanabe and Maiko Okada and Kazuki Inoue and Takashi Ueda and Ichiro Takada and Tetsuro Watabe and Yoko Yamamoto and Toru Fukuda and Takashi Nakamura and Chihiro Akimoto and Tetsuya Fujimura and Maiko Hoshino and Yuuki Imai and Daniel Metzger and Kohei Miyazono and Yasuhiro Minami and Pierre Chambon and Tadaichi Kitamura and Takahiro Matsumoto and Shigeaki Kato",
year = "2011",
month = "3",
day = "22",
doi = "10.1073/pnas.1014850108",
language = "English",
volume = "108",
pages = "4938--4943",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "12",

}

TY - JOUR

T1 - Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer

AU - Takahashi, Sayuri

AU - Watanabe, Tomoyuki

AU - Okada, Maiko

AU - Inoue, Kazuki

AU - Ueda, Takashi

AU - Takada, Ichiro

AU - Watabe, Tetsuro

AU - Yamamoto, Yoko

AU - Fukuda, Toru

AU - Nakamura, Takashi

AU - Akimoto, Chihiro

AU - Fujimura, Tetsuya

AU - Hoshino, Maiko

AU - Imai, Yuuki

AU - Metzger, Daniel

AU - Miyazono, Kohei

AU - Minami, Yasuhiro

AU - Chambon, Pierre

AU - Kitamura, Tadaichi

AU - Matsumoto, Takahiro

AU - Kato, Shigeaki

PY - 2011/3/22

Y1 - 2011/3/22

N2 - Prostate cancer development is associated with hyperactive androgen signaling. However, the molecular link between androgen receptor (AR) function and humoral factors remains elusive. A prostate cancer mouse model was generated by selectively mutating the AR threonine 877 into alanine in prostatic epithelial cells through Cre-ERT2-mediated targeted somatic mutagenesis. Such AR point mutant mice (ARpe-T877A/Y) developed hypertrophic prostates with responses to both an androgen antagonist and estrogen, although no prostatic tumor was seen. In prostate cancer model transgenic mice, the onset of prostatic tumorigenesis as well as tumor growth was significantly potentiated by introduction of the AR T877A mutation into the prostate. Genetic screening of mice identified Wnt-5a as an activator. Enhanced Wnt-5a expression was detected in the malignant prostate tumors of patients, whereas in benign prostatic hyperplasia such aberrant up-regulation was not obvious. These findings suggest that a noncanonical Wnt signal stimulates development of prostatic tumors with AR hyperfunction.

AB - Prostate cancer development is associated with hyperactive androgen signaling. However, the molecular link between androgen receptor (AR) function and humoral factors remains elusive. A prostate cancer mouse model was generated by selectively mutating the AR threonine 877 into alanine in prostatic epithelial cells through Cre-ERT2-mediated targeted somatic mutagenesis. Such AR point mutant mice (ARpe-T877A/Y) developed hypertrophic prostates with responses to both an androgen antagonist and estrogen, although no prostatic tumor was seen. In prostate cancer model transgenic mice, the onset of prostatic tumorigenesis as well as tumor growth was significantly potentiated by introduction of the AR T877A mutation into the prostate. Genetic screening of mice identified Wnt-5a as an activator. Enhanced Wnt-5a expression was detected in the malignant prostate tumors of patients, whereas in benign prostatic hyperplasia such aberrant up-regulation was not obvious. These findings suggest that a noncanonical Wnt signal stimulates development of prostatic tumors with AR hyperfunction.

KW - Antiandrogen

KW - Hormone-refractory state

KW - TRAMP

UR - http://www.scopus.com/inward/record.url?scp=79953213352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953213352&partnerID=8YFLogxK

U2 - 10.1073/pnas.1014850108

DO - 10.1073/pnas.1014850108

M3 - Article

VL - 108

SP - 4938

EP - 4943

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 12

ER -